November 23, 2015
Patients with a life-threatening genetic disorder tried to restart their case against Sanofi subsidiary Genzyme in the First Circuit on Friday, arguing that a Massachusetts federal judge had been too hard on their claims that their health suffered during a production slowdown of a crucial drug.